These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 31048668)

  • 21. Multiple Regional Listing Increases Liver Transplant Rates for Those With Model for End-stage Liver Disease Score <15.
    Brown S; Savva Y; Barth R; LaMattina J; Thuluvath PJ
    Transplantation; 2020 Apr; 104(4):762-769. PubMed ID: 31568393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A model including sarcopenia surpasses the MELD score in predicting waiting list mortality in cirrhotic liver transplant candidates: A competing risk analysis in a national cohort.
    van Vugt JLA; Alferink LJM; Buettner S; Gaspersz MP; Bot D; Darwish Murad S; Feshtali S; van Ooijen PMA; Polak WG; Porte RJ; van Hoek B; van den Berg AP; Metselaar HJ; IJzermans JNM
    J Hepatol; 2018 Apr; 68(4):707-714. PubMed ID: 29221886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatic encephalopathy is associated with significantly increased mortality among patients awaiting liver transplantation.
    Wong RJ; Gish RG; Ahmed A
    Liver Transpl; 2014 Dec; 20(12):1454-61. PubMed ID: 25155379
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Model for end-stage liver disease and model for end-stage liver disease-Na scores predict both before-listing and wait-list mortality.
    Yamashiki N; Sugawara Y; Tamura S; Kaneko J; Nojiri K; Aoki T; Sakamoto Y; Hasegawa K; Koike K; Kokudo N
    Transplant Proc; 2012 Mar; 44(2):389-92. PubMed ID: 22410024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypoalbuminemia is Associated With Significantly Higher Liver Transplant Waitlist Mortality and Lower Probability of Receiving Liver Transplant.
    Ahn J; Sundaram V; Ayoub WS; Frenette C; Wong RJ
    J Clin Gastroenterol; 2018; 52(10):913-917. PubMed ID: 29356783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disparities in Eurotransplant liver transplantation wait-list outcome between patients with and without model for end-stage liver disease exceptions.
    Umgelter A; Hapfelmeier A; Kopp W; van Rosmalen M; Rogiers X; Guba M;
    Liver Transpl; 2017 Oct; 23(10):1256-1265. PubMed ID: 28650098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Should All Status 1A Patients Be Prioritized Over High MELD Patients? Concept of Risk Stratification in Extremely Ill Liver Transplant Recipients.
    Safwan M; Nwagu U; Collins K; Abouljoud M; Nagai S
    Transplantation; 2019 Oct; 103(10):2121-2129. PubMed ID: 30747840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical characteristics of human immunodeficiency virus patients being referred for liver transplant evaluation: a descriptive cohort study.
    Martel-Laferrière V; Michel A; Schaefer S; Bindal S; Bichoupan K; Branch AD; Huprikar S; Schiano TD; Perumalswami PV
    Transpl Infect Dis; 2015 Aug; 17(4):527-35. PubMed ID: 25929731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validation of the five-variable Model for End-stage Liver Disease (5vMELD) for prediction of mortality on the liver transplant waiting list.
    Myers RP; Tandon P; Ney M; Meeberg G; Faris P; Shaheen AA; Aspinall AI; Burak KW
    Liver Int; 2014 Sep; 34(8):1176-83. PubMed ID: 24256642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Definition, reasons, and risk factors for mortality of patients listed for liver transplantation - a single-center study.
    Peschel G; Kraft IC; Ilkhtchoui R; Schmid S; Sinner B; Scherer MN; Mueller-Schilling M; Weigand K
    Z Gastroenterol; 2020 Nov; 58(11):1065-1073. PubMed ID: 33197949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High risk of delisting or death in liver transplant candidates following infections: Results from the North American Consortium for the Study of End-Stage Liver Disease.
    Reddy KR; O'Leary JG; Kamath PS; Fallon MB; Biggins SW; Wong F; Patton HM; Garcia-Tsao G; Subramanian RM; Thacker LR; Bajaj JS;
    Liver Transpl; 2015 Jul; 21(7):881-8. PubMed ID: 25845966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined heart-liver transplantation in the MELD era: do waitlisted patients require exception status?
    Schaffer JM; Chiu P; Singh SK; Oyer PE; Reitz BA; Mallidi HR
    Am J Transplant; 2014 Mar; 14(3):647-59. PubMed ID: 24517245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Could metabolic liver function tests predict mortality on waiting list for liver transplantation? A study on 560 patients.
    Ecochard M; Boillot O; Guillaud O; Roman S; Adham M; Mion F; Dumortier J
    Clin Transplant; 2011; 25(5):755-65. PubMed ID: 21158918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum sodium and survival benefit of liver transplantation.
    Sharma P; Schaubel DE; Goodrich NP; Merion RM
    Liver Transpl; 2015 Mar; 21(3):308-13. PubMed ID: 25504743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improvement in the Outcomes of MELD ≥ 40 Liver Transplantation: An Analysis of 207 Consecutive Transplants in a Highly Competitive DSA.
    Nekrasov V; Matsuoka L; Kaur N; Pita A; Whang G; Cao S; Groshen S; Alexopoulos S
    Transplantation; 2017 Oct; 101(10):2360-2367. PubMed ID: 28319564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MELD as a metric for survival benefit of liver transplantation.
    Luo X; Leanza J; Massie AB; Garonzik-Wang JM; Haugen CE; Gentry SE; Ottmann SE; Segev DL
    Am J Transplant; 2018 May; 18(5):1231-1237. PubMed ID: 29316310
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of Italian Score for Organ Allocation System on Deceased Donor Liver Transplantation: A Monocentric Competing Risk Time-to-Event Analysis.
    Khouzam S; Pagano D; Barbàra M; Cintorino D; Li Petri S; di Francesco F; Ricotta C; Bonsignore P; Seidita A; Calamia S; Canzonieri M; Tropea A; Gruttadauria S
    Transplant Proc; 2019 Nov; 51(9):2860-2864. PubMed ID: 31711575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Black Patients Have Unequal Access to Listing for Liver Transplantation in the United States.
    Rosenblatt R; Wahid N; Halazun KJ; Kaplan A; Jesudian A; Lucero C; Lee J; Dove L; Fox A; Verna E; Samstein B; Fortune BE; Brown RS
    Hepatology; 2021 Sep; 74(3):1523-1532. PubMed ID: 33779992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Defining a Liver Transplant Benefit Threshold for the Model for End-Stage Liver Disease-Sodium Score.
    Beal EW; Akateh C; Tumin D; Bagante F; Black SM; Washburn K; Azouley D; Pawlik TM
    Exp Clin Transplant; 2020 Aug; 18(4):491-497. PubMed ID: 31050611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The race to liver transplantation: a comparison of patients with and without hepatocellular carcinoma from listing to post-transplantation.
    Patel MS; Kohn R; Kratz JR; Shah JA; Markmann JF; Vagefi PA
    J Am Coll Surg; 2015 Jun; 220(6):1001-7. PubMed ID: 25868408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.